Reddit Posts
Asking ChatGPT how exactly Paypal is going to shock the world
Consider Li-FT Power (TSXV: LIFT; US-OTC: LIFFF) as a potential value play in the lithium mining space
ARKK's Misfits - A Bet on the Comeback Kings:
$DNA Is In Play - The Merger/Partnership - Buying In Pre-Market
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment--why aren't the popping?
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
Mainz Biotech $MYNZ ($1.30) -- Expected news on Colorectal Cancer Detection Study before End of Year
Highly shorted biotech stocks like BEAM and DNA (Ginkgo Bioworks) getting squeezed right now
Award-winning Creative & Media Agency Deep Focus Takes Back Its Name Under New Ownership of Bright Mountain Media, Inc. (OTCQB: BMTM)
Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023
AVRW Partnership With LA-Based Facial Plastic Surgeon
MIT develops “quantum rods” to achieve uHD virtual reality; 5G holographic AR creates a digital track
$AVRW News: The Sera Labs, Inc. Announces Partnership With LA-Based Facial Plastic Surgeon Dr. Michael Persky
$AVRW News: The Sera Labs, Inc. Announces Partnership With LA-Based Facial Plastic Surgeon Dr. Michael Persky
Top stocks to keep an eye on tomorrow
DNA stock alert: Is Ginkgo Bioworks the next big AI stock?
$DNA and Google Cloud under $2: ARK Funds have amassed a huge amount of shares
Is a rational decision concerning the value and future of young companies possible?
Before the breakout, Buy these 3 penny stocks
Vivos Therapeutics (NASDAQ: VVOS) - Awaiting a Significant Breakout & Positive Cash Flow! 💰💹
Are penny stocks worth it? 3 to watch right now.
Emerging Giants: Don't miss out on these 3 penny stocks with multi-bagger potential
Predictmedix Inc. (CSE: PMED, OTCQB: PMEDF) Special Report
Sucralose? More like Bers-lose
Penny stocks to watch amid the banking crisis
Financial Results $MGOL: Revenues increased 19% Gross profit margin on sales rose to 68% (Sales boosted by succes from Messi)
Enterprise Group ($E.TO, $ETOLF.OTC): Cash Flow Machine, Deep Value, Squeeze Potential
This seems big: Generation Bio will receive a $40 million upfront cash payment, a pre-payment of research funding, plus a $36 million equity investment from Moderna, with the potential for additional milestones, fees, and royalties. It doesn't look shorted but seemed worth reading IMHO
MYNZ Multiple Near Term Catalysts Ahead - $50-$75 stock trading at $6/share
MYNZ Multiple Catalysts Ahead $50-$75 stock at $6/share
A POEM FROM CHATGPT 🔮🧠 TO CITRON 🍋🍋🍋
If you want to see if a company has covered their exposure to the bank failure, check their financial statement footnotes.
$APDN Have Potential? Tell me what you think
I Believe British Tobacco, Altria, The Kochs, and US Cannabis Have Conspired to Privatize the Entire Industry. Deal is imminent. My report:
How British American Tobacco, Altria, and The Koch Brothers Have Conspired with Nearly Every US Cannabis Operator, through the Lobbying System, to Privatize and Monopolize the Cannabis Industry. And the Deal is Imminent.
$APDN Have Potential? Tell me what you think
Moet Hennessy Louis Vuitton ($LVMH) - Too late to invest?
Does anyone have an efficient way of retrieving company press releases?
InnovaQor will enter Magic Quadrant as Mental Health EMR
Biotechs Moving in the Pre-Market: $VVOS, $CUBT, $ORTX, $VYNT, $VYNE
VVOS stock up 100 % in premarket after new news (news in Link)
Pharmagreen launches product to repair DNA damage (OTC PINKS: PHBI)
Investing in SynBio. What are some good public companies in this space worth exploring?
DNA stock. Could it be a good long term opportunity? 🤔
Tax Loss Selling Bounce Candidates-- $ONCR, $ISUN, $MIGI, $ONCS
Truman Show, Illuminati, Remembering Past Lives, Personal Experiences of Otherworldly Phenomena, What "They" don't want you to know.
$BNGO - Short interest up over past month, price continues to shoot up, almost 50% past month, and today they announced sales of their new DNA extraction solution
DNA develops synthetic biology to deter bio-terrorists
(OTCQB: PHBI) Pharmagreen Biotech Inc: High Quality Cannabis Play with Nutraceuticals Upside $PHBI
$MIGI $IMNX, $NURO, $JUPW, $VLSK, $APDN --Positive Momentum Expected Today
Sold 10 CSP’s on $DNA @2.50 for January’23!! I’ve done ZERO RESEARCH!! Let’s gooooo!!
Pharmagreen Biotech Inc (OTCQB: PHBI): Research Report $PHBI
Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch $PHBI
Does Cathies favourite stock $DNA hit support and is a buy?
(OTCQB:PHBI) Pharmagreen Revolutionizes the Nutraceutical Industry $PHBI
(OTCQB:PHBI) Pharmagreen Revolutionizes the Nutraceutical Industry $PHBI
$DNA Long Term Outlook & Why I Am Bullish
AncestryDNA just informed me that I have DNA placing me in the highest category of risk-takers!
PMVP is the 2nd most shorted stock right now.
Gingko Bioworks - DNA - Biosecurity Division Killing It
20% of $DNA stocks are shorted. Bullish???
DNA - Ginkgo Bioworks Holdings, Inc. rock the sky 10$ by 17 August 🚀🚀🚀
DNA - Ginkgo Bioworks Holdings, Inc 300%🚀
$PACB: potential 5-bagger, long-ish writeup. re-posting from WSB bc y'all the real ones
$PACB: Cathie Wood is an idiot, but this is a 5-bagger. Long writeup.
$PACB: more than Cathie Wood's dumb ass will tell you
$DNA trading halted at 10:38 am - anyone know why?
The number of coronavirus tests in Hong Kong has risen rapidly, and leading enterprise Prenetics have continued to benefit
The number of coronavirus tests in Hong Kong has risen rapidly, and leading enterprise Prenetics have continued to benefit
Mentions
The draft registration statement that precedes the s1 is always confidential. The fact the s1 is now public means QMLS can pretty much go public any time they want because they are direct listing and not doing an IPO. So they have been holding back already for a month. Question is: why? Obviously they are waiting for funds from somewhere. The most interesting thing for me is that the draft registration statement was submitted just 2 weeks after the LOI with Party X was signed and just 10 days before DNA X LLC was registered in Delaware.
I live in 1980’s Miami. Making bad choices is in my DNA.
8k filing confirming asset sale and DNA X rebrand dropped. All debt cleared with $6.2 million in the bank. Fingers crossed for PIPE news on Monday, although press release seems to suggest more news "in coming weeks".
8k filing confirming asset sale and DNA X rebrand dropped. All debt cleared with $6.2 million in the bank. Fingers crossed for PIPE news on Monday, although press release seems to suggest more news "in coming weeks".
You need to split the name from the business. Sonim the rugged phones busines has been sold to Nexa. The company that is/was NAMED Sonim is now DNA X, a DeFi company. Asset sale finalized, 8-K incoming, and the stock ticker will soon switch to show that the company is now DNA X. This company, DNA X, purchased the DNA X protocol from DNA holdings and gave DNA Holdings a put options to take back their protocol if DNA X doesn't put up truly insane numbers by July of THIS YEAR. Thesis rests on the speculation that the way they intend to do that is by leasing Qumulus' GPU fleet (plus another ~6000 more).
If anything, it means that the company operating under the SONM ticker is now fully and solely tied to the DNA X platform business, and will soon be changing the ticker as a result (as indicated in the recent 8-K). As of now we're officially a DeFi business, and even with the pump today I would venture to say that this isn't the full market reaction; once the ticker flips I would think more will jump in. Even if not though, it doesn't matter. This isn't the big news, it's just another domino being set up for the real thesis underlying
Hello! This is very interesting. How long do you envisage we will have to wait for any Qumulus-news to drop? The DNA-X piece is just an little bit of nothing to keep the lights on
putin has a guy with a briefcase who collects his poop when he travels. It’s so he can maintain DNA opsec and probably maintain body doubles secrecy. There is evidence of the US doing weird stuff too for opsec.
Bro I been saying this for years. Humans are monkees. Monkees want tangible things like shiny rocks. For the average person btc seems fake and gauy techbro fairytale money. Humans have seen gold and silver for as highly valuable for >6000 years. It's practically in our DNA at this point.
I hate to burst that bubble, but trust me when I say that's when Trump deliberately defaults. It's in his DNA. He'll rant about how "They're treating us very badly. Very badly. These 'investors' take our interest payments like greedy pigs. Guess what? We're going to ask them for an immediate 50% haircut of the principal - and they'll do it. People come up to me all the time and they say 'Sir, we'll do it, we've treated you very badly'...And they're right."
We're men. We love the same old tired jokes. It's part of our DNA.
**$NEOV (NeoVolta Inc.):1000% upside!!!!** # 1. The "Tesla DNA" & The Power Partnership 🔋 This isn't just another penny stock. **Longi Green Energy** (the world's largest solar giant) and its subsidiary, Jingkong, are forming a massive Joint Venture (JV) with **$NEOV**. * **The Alpha:** $NEOV holds a **60% majority stake** in this JV. * **The Pedigree:** NEOV’s management team consists of **Ex-Tesla Energy veterans**. These are the people who actually know how to scale storage, not just talk about it. # 2. Massive Capacity Expansion (The Gains Factory) 🏗️ They aren't just selling batteries; they’re building a goddamn empire in North America: * **The Plan:** Building a **2GWh storage battery plant** on US soil. * **Timeline:** Production starts mid-2026. * **The Vision:** Scaling up to a **long-term goal of 8GWh**. # 3. The Math (Why this is a 10-Bagger) 💰 Let’s do some "ape math" based on the long-term 8GWh target: * **Revenue:** 8GWh capacity = **$1.6 Billion** in total revenue (per company guidance). * **NEOV’s Cut:** With their 60% stake, we’re looking at roughly **$1 Billion** in consolidated revenue. * **The Valuation:** Look at **$FLNC (Fluence)**. They trade at a 1-2x P/S (Price-to-Sales) ratio. * **Price Target:** At a 1-2x P/S, $NEOV’s market cap should be **$1B to $2B**. * **Upside:** Compared to current levels, we are looking at **500% to 1,000% gains.**
I'm not asking for much, just for Michael Saylor and anyone sharing more than 25% of his DNA to have their net worth entirely eradicated and their names stricken from the history books
Even of you don't own the company, TWST is a great follow because they post about a lot of the genetic research their products are helping. This morning hey posted an article about a new development in HIV research using their synthetic DNA. Pretty amazing stuff to see.
Actually, the the illuminating part: It's not the fastest sperm, in fact they get up in there and hang out in the fallopian tubes for up to three days, waiting for the egg to drop. And the one that wins is chosen by the egg, which sets the protein on the outer membrane to only permit the chosen spermatozoa to dump its DNA load in... So really, it's the egg's judgement that at question...
Good question, and the answer is what looks like convergence and co-ordination between all 5 parties involved - SONM, Qumulus AI, Permian Labs, Chardan & DNA. * SONM filing 8k confirming asset sale (and probably QAI PIPE) * Likely PYUSD deployment by Permian Labs * [QAI attending PTC](https://www.linkedin.com/posts/qumulusai_ptc-ptc26-aiinfrastructure-activity-7417247833814179840-iVDw?utm_source=share&utm_medium=member_desktop&rcm=ACoAAEWkMOQBN3ZVHz6_kZYHlsRsRAkC-zQzcNQ) in Hawaii with focus on edge AI/telecom and capital markets guy is on their team at the event. 4,000 companies are attending. * Mike Maniscalco on a hyperscaler panel on Tuesday at above event * [DNA X & Chardan co-sponsoring an event ](https://puertorico.srax.com/)on Tuesday/Wednesday/Thursday in Puerto RIco where the main panel is investing in decentralised AI infrastructure. The main guests are family offices and equity groups. * Leasing accountant expert from Atlanta, Georgia (QAI HQ) presenting at DNA X event
DNA study reveals humans nearly vanished 800,000 years ago, with just 1,280 people repopulating Earth
You don’t know us. Not really. You’ve spent the last year thinking our silence was a white flag. You think because we’ve stayed civil while you’ve turned the Executive Branch into a Craigslist for sociopaths, that we’re soft? You think because we didn’t scream while Stephen Miller was drafting dark-web immigration fever dreams, or while Elon was live-streaming the dismantling of the American state like he was gutting a Twitter server room for sport, that we’ve surrendered? That is your first, and final, mistake. We see the DNA of the NYC slumlord scaled up to a national catastrophe. Donald, Don Jr., and Eric—you aren’t "statesmen." You’re just the same petty predators your grandfather was, only now you’ve traded a rent-controlled walk-up in Queens for the United States Treasury. You’re treating American tax dollars like a family ATM, continuing the noble family legacy of Fred Trump: stiffing the help, watering down the paint, and pissing on the people who actually build the world. We see the mouthpieces you hire to cover the smell. Karoline Leavitt and Margo Martin out there every day, lying with the soulless confidence of a timeshare pitch for a building that doesn't have a foundation. We see Mike Johnson gaveling away the very decency he claims to pray for, while Pam Bondi acts as the high-priced mob lawyer you always keep on retainer to keep the subpoenas at bay. You’ve got Pete Hegseth trying to run the Pentagon like a segment on Fox & Friends, and JD Vance—a man with more versions of his soul than a software update no one asked for. You’re all just "thin reeds." You’re Lutnick and Bessent auctioning off our children’s futures to the highest bidder at Davos while Kristi Noem looks for a gravel pit to bury the last of our national ethics. But get this through your thick, gold-plated, "grandfather-stole-this" skulls: Democracy and the global world order are made of the finest stuff on this earthly plane. They were built by people who actually sacrificed something—unlike you wretches who think "struggle" is when the gold leaf on the bathroom faucet starts to flake. You think your wealth makes you untouchable? That your dark corners on Epstein’s island or your "federal immunity" are magic shields? They aren’t. They’re just more things for us to take back. Which is why we will not allow you to hurt, hurt this country. If you f*** over our collective future to satisfy a slumlord’s greed, then f***ing you back will become our mission. Our sole m*****f***ing reason for being. We will use your own vanity, your own staggering incompetence, and your own public paper trails to dismantle everything you’ve stolen. We will come for you. We will systematically go over or through everything in our path until we have reached that objective. We may not know exactly how yet, but we will figure the f*** out. And we will, will get you. You’ll go on TV, drape yourself in a flag you never bled for, and give us your word. But your word is a thin reed. And we are going to watch it snap.
He’s not wrong. Tax laws in the Eurozone promote brain drain. They’ll never change, it’s built into their DNA to crush entrepreneurialism and the elites spending other peoples money.
OP's purported price target is $80/share, with math to support it. That's not a next week/next month number, but based on the put options that DNA was granted, leadership all seem to have EXTREMELY lofty expectations for the amount of money coming in in a very short amount of time. OP ran the math backwards using these projected revenue goals, P/Es of similar companies, etc. to come up with $80.
Why is SONM, under its new brand name DNA X, the Title sponsor of an event (along with Chardan) where the main panel topic is investing in decentralised AI, and the attendees are family offices and equity funds, on the day the SONM asset sale 8k has to be filed, while Qumulus AI are also attending a parallel event in edge AI attended by 4,000 companies? I've been arguing for the last month that QAI will be leasing their GPUs from SONM by separating the hardware/software layer. So it's also interesting that George Azih is also one of the main speakers at the DNA X event, who is from Atlanta (where QAI HQ is), and is an expert in lease accounting. There is no stretch here. Tuesday is a co-ordinated announcement.
I believe the 30 day period is a Nasdaq requirement. SONM will be subject to a separate legal requirement because they will no longer own the brand name, unless they obtain permission from social mobile to continue using it but I doubt it. Important to remember that DNA X is co sponsoring an event with Chardan on Tuesday in Puerto Rico and the main panel topic is investing in decentralized AI with family offices and funds attending. DNA will want the spotlight and will almost certainly demand the ticker name changes immediately.
Sorry, I don’t see the significance here other than the events having overlapping schedules… Maybe something could come out of the event with DNA relating to the thesis since it is specifically centered around investors but PTC is otherwise just an informative conference that Qumulus will be a part of?
SONM will be DNA X as of Tuesday. I expect Mike Mulica to be in Puerto Rico.
Everyone: this is happening. On Tuesday, Qumulus AI will be at [PTC ](https://www.ptc.org/ptc26/)where the main topic of focus will be telecom and edge AI. Mike Maniscalco will be on a panel. Simultaneously, DNA X will be hosting an [event](https://puertorico.srax.com/companies) in Puerto Rico, where Chardan is the title sponsor. The attendees are traditional investors: family offices, equity groups etc. Not crypto companies and crypto bros. Why is Qumulus AI's financial advisor in Puerto Rico sponsoring DNA X's event on the day Qumulus AI attend PTC, which is also the final day for the 8-k for the asset sale to be filed? Have a great weekend.
They did a DNA test and what they found wasn’t DNA, it was USA. He could have made an album with this bar but instead he wants Greenland
CFP down $300k in losses in 5 years but make $400k a year. Gambling is in my DNA.
**Blacks are proto-humans; modern man evolved from Blacks by hybridizing with the large-brain Neanderthals:** **• Blacks = 2% Archaic admixture** **• Whites = 3% Neanderthal** **• Asians = 3% Neanderthal + Denisovan** **Genetic distance is a measure of the genetic divergence between populations. Blacks have a genetic distance of 0.23 from Whites and Asians, but only 0.17 from Erectus. That means Blacks are more genetically proximate to archaic man than to modern man.** **Blacks are the only race with no DNA from the large-brain Neanderthals. Civilizations didn't begin until the Neanderthal hybridization created the larger brains in modern man:** **Brain Size by Race:** **• Black = 1267 cm³** **• White = 1347 cm³** **• Asian = 1364 cm³** **Brain Weight by Race:** **• Black = 1261 g** **• White = 1387 g** **• Asian = 1374 g**
Whites are only 10% of the world's population and the only race in population decline (creating only 7% of the world's babies), yet are the most industrious and innovative race the world has known. Whites unlocked the secrets of DNA and relativity, launched satellites, created automation, discovered electricity and nuclear energy, invented automobiles, aircraft, submarines, radio, television, computers, medicine, telephones, light bulbs, photography, and countless other technological miracles. Whites were the first to circumnavigate the planet by ship, orbit it by spacecraft, walk on the moon, probe beyond the solar system, climb the highest peaks, reach both poles, exceed the sound barrier, descend to the oceans depths... Blacks cannot even feed themselves. Whites domesticated Blacks and gave them everything they have. Whites created every country for Blacks, but now have to provide food, medical, financial, and engineering aid to every one. Blacks cannot survive without White charity. No pre-contact Black society ever created a written language, or wove cloth, or forged steel, or invented the wheel, or plow, or devised a calendar, or code of laws, or system of measurement, or math, or built a multi-story structure, or sewer, or drilled a well, or irrigated, or created any agriculture, or built a road, or sea-worthy vessel. They never domesticated animals, or exploited underground natural resources, or produced any kind of mechanical device. Blacks were still living in the Stone Age when Whites discovered them just 400 years ago.
Reminder of the Water 🐻: https://i.imgur.com/ekZ4g8o.png Also known as moss piglet, is the most punishment accepting animal known to exist. Despite appearing soft and squishy (some might say cute with little claws and sticky pads on their legs) they have a tough outer exoskeleton and can withstand the most extreme conditions. They can: * Survive 30 years starving with no food or water. * They can be thoroughly dried out, exposed directly to the vacuum of outer space. Then revived back on earth and still reproduce. * Stay alive through near absolute zero temperatures of -393°F to as high as 284°F well above boiling. * Be compressed to almost 100,000 pounds per square inch (psi) or six times the deepest ocean trenches. * Endure doses of radiation more than 1,000 times the amount lethal to humans through the production of special proteins that shield DNA and help repair damage. * Curl up into a dormant "tun" state when conditions become harsh and shutting down metabolism to completely undetectable levels. According to molecular evidence, they have existed for 600 million years, predating dinosaurs by several hundred million years and outlasting them. This is what 🐂 is up against.
Why is no one talking about the danger of EMF radiation We’re surrounded by EMF radiation constantly, phones,WiFi,5G towers, power lines but no one really talks about what it’s doing to us. A UC Berkeley study found that just 17 minutes a day on a phone for 10 years increases brain cancer risk by 60% The CDC has even linked EMFs to two types of brain tumors. Other studies show EMFs disrupt hormones, damage DNA, and cause oxidative stress which accelerates aging and leads to chronic health issues. The craziest part? The telecom industry spends over $130 million a year lobbying to keep this quiet. The government even stopped funding research on EMF dangers back in the ‘90s. Its not like we can avoid EMFs. Even if you don’t use WiFi your neighbors do. Even if you don’t own a phone, youre still getting hit by signals from satellites, smart meters, and cell towers. I
Another note to say that asset sale deadline is end of today. It's possible both parties could extend if they they need more time, but I'm hopeful this won't be the case given the put options in the DNA X filing suggest SONM needs to start executing its new line of business ASAP. Once the asset sale completes, SONM will have UP to 5 days to file an 8k confirming the transaction. I would expect a PIPE announcement to go hand-in-hand with the asset sale transaction or to follow shortly thereafter. Given that we did not get news yesterday or before markets opened today, it is highly unlikely they will drop good news mid-week. I would therefore expect the asset sale filing to drop AH this Friday with PIPE announcement on Tuesday before markets open, as Monday is a bank holiday.
DNA results are in. You are the father
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
CVNA “Enron / Ponzi-Style Risk Pattern” Thread (Source-Linked) 1️⃣ Enron collapses always share the same DNA: complexity, related-party economics, aggressive accounting optics, and absolute dependence on continuous financing. Enron reference (DOJ summary): https://www.justice.gov/archive/enron/ 2️⃣ Carvana has disclosed extensive ongoing related-party transactions with DriveTime (Garcia family entity) that materially affect revenue, inventory, commissions, warranties, profit-sharing, servicing fees, and payables. Source (CVNA 2024 10-K – SEC): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 3️⃣ These include: • Wholesale vehicle sales • Retail inventory purchases • Warranty & VSC commission sharing • Servicing/admin fees • Profit-sharing agreements • Related-party payables & tax receivable obligations (Source: same 10-K above) 4️⃣ This matters because related-party pricing is not arm’s-length — small contractual changes can materially swing reported gross profit and EBITDA. SEC guidance on related-party risk: https://www.sec.gov/oiea/investor-alerts-and-bulletins/ib_relatedparty 5️⃣ Carvana’s entire retail model is dependent on warehouse lending & securitization facilities to fund finance receivables. Source (CVNA 10-Q, June 2024 – SEC): https://www.sec.gov/ixviewer/documents/2024-08-07/cvna-20240630x10q.htm 6️⃣ This creates a classic Ponzi-style structural risk: when funding tightens, originations fall, margins compress, liquidity spirals — equity collapses after credit confidence breaks. General forensic finance principle (IMF): https://www.imf.org/external/pubs/ft/gfsr/ 7️⃣ Carvana already had to restructure its capital stack in 2023, exchanging over 96% of its unsecured bonds into newly issued secured debt. Company filing: https://investors.carvana.com/news-releases/2023/08-31-2023-141011765 8️⃣ Debt exchanges of that scale are widely recognized as distress repair events — often a precursor to deeper restructuring cycles. Academic reference: https://www.jstor.org/stable/40985723 9️⃣ Carvana’s accounting is highly sensitive to inventory pricing, reconditioning costs, warranty reserves, and GPU assumptions. Source (MD&A, CVNA 10-K): https://www.sec.gov/ixviewer/documents/2025-02-20/cvna-20241231x10k.htm 🔟 Short sellers and class-action plaintiffs have already alleged inflated economics and undisclosed fragility (allegations — not findings). Hindenburg (Jan 2025): https://hindenburgresearch.com/carvana/ 1️⃣1️⃣ Carvana joined the S&P 500 in December 2025, forcing passive funds to buy it regardless of fundamentals. S&P Dow Jones: https://press.spglobal.com/2025-12-05-CRH%2C-Carvana-and-Comfort-Systems-USA-Set-to-Join-S-P-500-Others-to-Join-S-P-MidCap-400-and-S-P-SmallCap-600 1️⃣2️⃣ Index math: CVNA ≈ $94B market cap vs S&P ≈ $58T → ~0.16% index weight. Sources: https://stockanalysis.com/stocks/cvna/market-cap/ https://www.slickcharts.com/sp500/marketcap 1️⃣3️⃣ A 50% CVNA crash would mechanically shave ~0.08% off the S&P, but the real risk is second-order contagion through consumer ABS, subprime auto credit, and leveraged growth equity repricing. 1️⃣4️⃣ This is exactly how Enron’s collapse spread — not through index weight, but through counterparty trust collapse and credit repricing. Federal Reserve history: https://www.federalreservehistory.org/essays/enron 1️⃣5️⃣ Bottom line: CVNA doesn’t need hidden SPEs to behave like an Enron-style failure. Complexity + related-party economics + financing dependence = the same structural collapse profile.
TWST releasing preliminary Q1 results. Fiscal 2026 First Quarter Preliminary, Unaudited Revenue Total revenue for the first quarter of fiscal 2026 grew 17% to approximately $103.7 million (+/- $0.2 million) compared to the same period of fiscal 2025. • DNA Synthesis and Protein Solutions revenue grew 27% to approximately $51.1 million (+/- $0.1 million) for the first quarter of fiscal 2026. • NGS Applications revenue grew to approximately $52.6 million (+/- $0.1 million) for the first quarter of fiscal 2026, ahead of guidance expectations.
It’s in the DNA. This nation was built by religious fanatics and crazy adventurers. Magical thinking + risk tolerance
The EU always talks and talks and taaaaalks before doing something. It's in its DNA. But more often than not, it does do something eventually, if the need is pressing enough. It feels like that point is close. All that aside though, part of this is also me using disposable income to invest in the future I want to see, not to mention my personal security.
Probably looking in a slightly unlikely place, but I think Amazon is the one that could be the ‘Google’ of 2026 (large cap, trough to peak gain of over 100%). I’ve got 2 major reasons for that, neither of which are the focus of earnings calls or media commentary most of the time: robotics and also the investments made in that space over the last decade and also the Kuiper project. Robotics here isn’t attention grabbing humanoid things that might do your household tidying but the non-humanoid industrial robots that allow their now global fleet of custom designed fulfilment centres to operate with higher throughput, efficiency and return on invested capital. And Kuiper as an alternative to incumbents and Starlink as an internet service provider is just so interesting because of the distribution advantage that Amazon has over every other provider via its touchpoint with end users via Amazon Prime. Bundle high speed internet with your prime sub, they’ve already got your billing details, $50 a month, could be a $10 billion dollar a year revenue run rate business in a very short order given the low friction to adopt and the fact their balance sheet could absorb below market revenue in order to build a long-term business franchise (a feature of their corporate DNA). It’s also statistically very cheap relative to its own history on the main metric I use to track that measure.
Real reddit question: "How did people in the middle ages know what skeletons look like without X-ray machines?" Real reddit question: "How did you add the clouds in the background?". OP: "that's the sky, we're outside." Real reddit question: "why do the women never have to take a DNA test to see if it's their child"
Apply for custody Do a DNA test and get your boyfriend to provide "your" sample Propose to the mom Change ur name and emigrate
I mean, they're working on memory storage that uses DNA strands to write and store data, so technically, you're correct....
Illumina made its name owning DNA genome sequencing, but that space is pretty mature at this point. The next big thing people are excited (ok its still underrated but it will be like quantum computing e.g. nov 2024 before it explodes) about is proteomic sequencing because proteins are what actually drive biology and disease and that’s still super early. That's why QSI is interesting. It’s trying to do for proteins what Illumina did for DNA. On top of that, Jonathan Rothberg who literally helped invent next-gen DNA sequencing, is heavily involved and openly pushing proteomics as the future. Given Illumina track record of buying disruptive tech to stay ahead, it’s not crazy to think they’d rather acquire a company like QSI than risk being left behind if proteomic sequencing really takes off.
Sarah Jessica Parker has to have at least 30% equine DNA
Or perhaps it’s been exactly the right strategy in an environment where billions are being spent on foundation models without a clear return on investment and no evidence that consumers will pay additional amounts for generative AI capabilities (e.g ChatGPT’s low single digits paid to free user percentage)? The strategy to preserve capital and allow the ‘arms race’ to play out also allows Apple to negotiate with providers to enter partnerships on favourable terms or even get paid to host a particular model (the way Google pays Apple to have Apple as the default search option on iOS). This is in line with Apple corporate DNA of being a ‘fast follower’ in terms of tech (adopting second, optimising for users and keeping ecosystem lock in). E.g. Samsung Galaxy phones have all the major tech advances before iPhones do (Haptic Touch, face ID, etc) but Apple still captures most of the profit pool for smartphones.
DNA holdings got 200k shares in exchange for giving SONM the DNA X platform and a 1.2 million bridge loan. This deal was done to help SONM keep the lights on, clear toxic debt and prevent SONM being designated as a shell by the SEC, which would have been disastrous. In exchange, DNA Holdings got 200k shares in a company that is about to re-rate as an AI infrastructure company. 200k shares in a company that might re-rate soon to $100 = $20 million. If that isn't profit for brokering a deal I don't know what is. The DNA X platform itself is irrelevant - it's just a temporary placeholder to "prove" to the SEC that there is a line of business in between the asset sale vote happening and the asset sale closing.
What I don’t fully understand are the mechanics of the agreement with DNA Holdings and, if your scenario is correct and they experience significant dilution, how exactly would DNA benefit or profit from this arrangement/structure?
Probably looking in a slightly unlikely place, but I think Amazon is the one that could be the ‘Google’ of 2026 (large cap, trough to peak gain of over 100%). I’ve got 2 major reasons for that, neither of which are the focus of earnings calls or media commentary most of the time: robotics and also the investments made in that space over the last decade and also the Kuiper project. Robotics here isn’t attention grabbing humanoid things that might do your household tidying but the non-humanoid industrial robots that allow their now global fleet of custom designed fulfilment centres to operate with higher throughput, efficiency and return on invested capital. And Kuiper is just so interesting because of the distribution advantage that Amazon has over every other provider via its touchpoint with end users via Amazon Prime. Bundle high speed internet with your prime sub, they’ve already got your billing details, $50 a month, could be a $10 billion dollar a year revenue run rate business in a very short order given the low friction to adopt and the fact their balance sheet could absorb below market revenue in order to build a long-term business franchise (a feature of their corporate DNA). It’s also statistically very cheap relative to its own history on the main metric I use to track that measure.
AI will solve cancer with gene splicing using CRISPR to completely eliminate it from our DNA.
RTO isn't happening, as per the title of this post. DNA X can't hit the 600 million volume/1 million revenue/day without the 30% deposit Permian Labs needs to give Qumulus AI the 70% leverage. They cannot wait until SEC approval that would take 3-6 months. Add another 3 months to raise the capital for the B300s and another 3 months for them to deliver and suddenly B300s are irrelevant with NVIDIA rubins delivering in H2 2026. Qumulus AI need to raise cash via the markets immediately - they are running out of time. The only vehicle that is ready to do that is SONM. Predictive Oncology have a lot of Aethir on their books but their filings say don't intend on converting that to any other stablecoins (which would have to happen to buy USDC to then convert and stake USD.AI.)
I'm aware. They did a PIPE into Predictive Oncology which is becoming an Aethir treasury. Interestingly, the Aethir team collabed earlier in the year with Metastreet (Permian Labs) on another project. Both teams are looking at bridging crypto with AI in similar ways. But effectively this creates an indirect link between all parties. SONM <----> DNA X DNA X <----> Aethir Aethir <----> Permian Labs Permian Labs <-----> Qumulus AI
Did you see DNA HOLDINGS also did a Pipe in October with another crypto company for 344 mill. They’ve got 15% chardan dos the chef and streetville has just under 10, so could be this whole dance is just setting table to move depending on how sec rules on qumulus direct listing as that says they’ll abandon if rejected. Which I suspect means whole thing is sonm or we do the gpu split with sonm https://www.dlnews.com/external/dna-holdings-orchestrates-landmark-3444m-capital-deal-bridging-nasdaq-listed-company-with-aethirs-decentralized-ai-infrastructure/
Add in TRNS as a servicer to biotech. I believe ATS does a lot of biotech automation too. TWST as the provider of synthetic DNA for testing.
One of the reasons TWST is finally moving is that the market is seeing that it's a huge AI play. GOOG has apparently been buying their synthetic DNA to test solutions developed through DeepMind. TWST is the only company capable of making enough product to meet the demand. This sets up TWST to be the picks and shovels play for a massive AI driven market. I'm adding more on pullbacks.
Right on. ...going back to pharma (and the associated TAM), MRNA, Moderna, has been good to me in the last few months. They literally have cancer cures (amongst others) in the pipeline, and should outperform once the market starts pricing them as more than a COVID treatment. Similarly, NTRA, Natera, has some interesting DNA diagnostics. Getting a bit pricey, but I'm willing to at least hold until Druckmiller sells.
It's sort of a moonshot type play, but the concept of DNA storage and computing has been contemplated for a long time. As far as who wants it? No idea now, but at least Microsoft invested in the company and has purchased strands to experiment with. I believe Bezos' company has done the same, but can't recall. It's also a known moonshot. TWST spun it out because they knew it was a "science project" and probably detracting from their overall value. It's really a fun free call option on the main thesis of TWST, which actually includes people studying cancer treatment, among other things. I can't imagine that much data either, but the way we can generate data via AI will cause the amount of information out there to explode. This is an interesting solution to store it. We'll see how it works out. It could have uses in very small things. Possibly medical nanites that can operate inside a human body. Probably a lot of other things I haven't even contemplated.
So is the idea that data gets converted to ACGT quarternary and stored as a DNA sample? Sounds like something from sci-fi but not particularly practical or needed. Someone can place 13 TB of digital data on a $100 hard drive, which doesn’t need any special storage and is already geared for retrieval/read/write/edit.
From TWST on X: "Congratulations to Atlas Data Storage on their launch of Atlas Eon 100, which is the first scalable DNA storage service, & roadmap to storage densities to place 13TB of digital data into a volume described as a single drop of water." TWST spun out atlas data storage in 2025 but still has an ownership stake in the company.
The tracker doesn't show what happened after assignment. I saw that FIG, PRME got assigned away for more premium, but your tracked doesn't show the profit on the shares. I see that you also ran CCs on ACHR, NTLA, but no assignement yet, so still holding them? Are you still holding RCAT? FLY? DNA? Looks like they all may have recovered since assignment, although not sure what price you were assigned at and on what date. Is there away to add columns in the tracker to show the full chain of events after assignment?
I opened a RH account years ago when they were new. I have accounts at a variety of brokers, so I can compare them (I have worked in UI/UX) and also so I can compare different trading strategies more easily to see what works for me and what doesn’t. Robinhood has been a lot of fun and they are a real broker. The usability is excellent, better than any other broker. The app is based on the earlier versions which were “gamified”, and a lot of that is still in the DNA. It’s just fun to play in. The benefits of things like the “Gold” or the credit card (3% cash back) are legitimate, if small. But no other broker offers more, so it is what it is. The only downside to a Robinhood account is the price action on order fills. You will generally pay more if you put in a market order, as RH makes money on order flow. But if you only use limit orders, you can more or less get past this downside easily. I don’t have a lot of money there, so I can’t say if they are more responsive if you have a large account, but the responsiveness on a small account level is reasonable. You won’t talk to people unless you absolutely need to and hop through hoops to get them. But eventually you can talk with people.
I think most people are missing how Rivian is positioning itself as an EV platform provider in addition to an EV manufacturer. It took Tesla twelve years to become profitable from the time they began selling their first car. Unlike Tesla, which has struggled to actually ink any licensing deals for its hardware or software to date, Rivian was able to secure a $5.8B commitment from the VW Group within 4 years of its first vehicle rolling off the line, and the structure of the Rivian-VW joint venture ([RV Tech](https://rivianvw.tech/)) is the key differentiator here. VW is the sole source of capital investment into RV Tech as part of this deal. VW offered Rivian a $1B convertible note (which was of course converted and repaid with equity in RIVN) and $1.3B cash money in exchange for 1) 50% equity in RV Tech and 2) a licensing deal to use Rivian's existing IP in the meantime. VW will provide up to an additional $3.5B in funding for RV Tech through 2027. Rivian's main financial obligation is funding 25% of the shared platform R&D costs through 2028. And starting in 2029, VW will increase their funding by an incremental amount annually to further reduce Rivian's costs. This allows Rivian to develop its next-gen zonal architecture and base systems and infotainment software stacks using VW’s capital while retaining 50% ownership of the new IP. It's free real estate for Rivian. What Rivian considers its core DNA (drivetrain, battery design, and autonomy stack) are not part of this deal and will remain exclusive to them. Tesla’s valuation is definitely propped up by Musk hyping their energy, rideshare, and robotics divisions, but Rivian is the first EV startup to prove that its software and electronics architecture are valuable enough for a legacy giant to pivot its entire future toward it. With the R2 coming this year and the R3 in 2027/28, I just cannot see anything but growth for the company.
I think this frames Amazon a bit narrowly as a “product company” in the consumer sense. Amazon’s edge has historically been operational + platform DNA, not polished end-user products. In AI, that actually maps pretty well to infrastructure, tooling, and distribution — which is why AWS, custom silicon, and internal ML deployment matter more than a breakout consumer AI product. They may never “lead” AI the way Apple leads hardware or OpenAI leads models, but they don’t need to. If AI becomes embedded across commerce, logistics, cloud, and enterprise workflows, Amazon can still be one of the biggest beneficiaries without winning the narrative.
Proxy No. The Company does not intend to liquidate following the consummation of the Asset Sale and currently intends **to engage in the Successor Business and/or** to pursue a strategic transaction, the terms and timing of which are not presently known. However, there can be no assurance that any such transaction will be pursued, agreed upon, or ultimately consummated. litigation that needed resolving Currently, the Company **is in receipt of multiple demand letters in connection with the Proxy Statement. While it** is not aware of any complaints filed or litigation pending related to the Asset Purchase Agreement**. However**, litigation is a common occurrence in connection with transactions similar to the proposed transaction, so we face potential for litigation or other disputes that relate to the Asset Purchase Agreement, including claims related to our process or disclosures and investigatory demands under Delaware law. We can provide no assurance that such litigation, disputes, or demands will not arise in the future. Any such litigation, disputes, or demands, whether successful or not, could delay the closing of the Asset Purchase Agreement or could have a material adverse effect on our business, results of operations, and financial condition. the transactions contemplated in proxy don't apply to DNA transaction Upon the occurrence of a “Change of Control Transaction” (as defined in the DNA Note), the Company is required to redeem the outstanding principal amount of the DNA Note for cash at a price equal to 110% of the then outstanding principal amount, plus accrued but unpaid interest and any other amounts then due under the DNA Note (the “Redemption Amount”), at the closing of such transaction. Notwithstanding the foregoing, the transactions contemplated by the Asset Purchase Agreement do not constitute a Change of Control Transaction under the DNA Note. In lieu of receiving the Redemption Amount, and subject to any required stockholder approval under the rules of the Company’s principal trading market, the holder may elect to convert the DNA Note, in whole or in part, upon a Change of Control Transaction at a price per share equal to the lower of (i) the closing price of common stock on the original issue date of the DNA Note and (ii) the closing price of common stock on the date of consummation of such Change of Control Transaction. The document quote where everything may not be publicly listed The foregoing descriptions of the Transaction Documents have been included to provide investors with information regarding the terms of the Transaction Documents. They are not intended to provide any other factual information about the Company, DNA Holdings, or their respective affiliates. The representations, warranties, and covenants contained in the Transaction Documents were made only as of specified dates for the purposes of the Transaction Documents, were solely for the benefit of the parties to the applicable Transaction Documents and may be subject to qualifications and limitations agreed upon by the parties. In particular, in reviewing the representations, warranties, and covenants contained in the Transaction Documents and discussed in the foregoing description, it is important to bear in mind that such representations, warranties, and covenants were negotiated with the principal purpose of allocating risk between the parties, rather than establishing matters as facts, and may have been qualified by confidential disclosures. Such representations, warranties, and covenants may also be subject to a contractual standard of materiality different from those generally applicable to stockholders and reports and documents filed with the SEC. Accordingly, investors should not rely on such representations, warranties, and covenants as characterizations of the actual state of facts or circumstances described therein. Information concerning the subject matter of such representations, warranties, and covenants may change after the date of the Transaction Documents, which subsequent information may or may not be fully reflected in the parties’ public disclosures. street Ville is an exhibit on it
I think the biggest things are 1. In proxys they say other deals are in play. 2. Litigation was over the asset sale likely because of shell. In a comment I had earlier I said I felt a lot better in things when I saw this short term company announced. Dnax basically is a shell holder that can convert back or convert into shares. 3. Asset sale cures the outstanding debt to make it clean. I suspect asset sale happens at some point this month, barring injunction from lawsuits. I believe dna x moots the law suits as there is a plan. I don’t see nexim pulling out if not done exactly on the 13th. They are at the finish line and want this stuff. Proxy read in connection with 8k is needed, as 8k has to be more exact proxy can have forward looking. My guess asset sale maybe goes through mid month, may need a bit more time depending on if any emergency injunctions. Once that is through funds clear to accounts debts are paid, and confirmed to be paid. They do a final round of due diligence. Then the rto pipe goes down If you read the streetville stuff in the 19th filing it says materials made privy to them is why they did the swap. If there is an asset sale to pay off debts. Why would you convert to shares of a failing company, which obviously dilutes and leads to a decrease but for you know there’s more afoot. I don’t see any weird BAGS shell being used and two tickers. I think it’s more they knew they couldn’t get the PIPE done by the 13th. They needed accounts to settle. SONM can’t go shell so they set up a placeholder business that is in reality 1.2 mill in shares to keep the lights on. Basically DNA Venture DNAX so that they could keep Bags from a shell, and to make sure they do the i’s and t’s right so no regulatory issues. Keeps them from a tight turn around window, and to stay comfy If you read th dnax portion it has one dilution exemption which is a transaction/takeover that they are privy too or something like that. Basically there’s one loop hole and its qumulus or whatever big dog is prepping to rear its head. With qumulus reverse split and bags both in October I think odds are it’s probably qumulus
Your great great great great great ancestor had .05% DNA according to genealogy site. You deserve that 5 mil 😂
Folks here tend to be opportunistic traders. I do not mean that as an insult. That said, I am a grower of many things. It just turned out when I was growing seed from a 1979 era Columbian Gold OG seed (doesn't exist anymore AFAIK) over the next twenty years of my guerilla grows I grew cannabis. I understand nurseries as much of my side revenue was microgreens based on what I learned with guerilla grows. Ok. So that said, your seeds are almost certainly dead. Seeds are bundles of sugar with some DNA engines around it. No moisture, no plant - viable seeds are in my experience simply batteries with no charge in at best case seven years. You want to preserve them? Find someone who knows how to grow. The seeds have no intrinsic value themselves. If you have the skills germinate and then grow, let the males and females mate, sprout their seeds, and maybe in two years you have a stable predictable seed strain. I'm not optimistic. And honestly those strains you have were already unstable mutations. Seriously though, find a real grower, don't have high (ahem) expectations, and see what happens. As near as most folks can tell the last OG Indica and Sativa genetics died out roughly in the early 2000s. Growers then had no idea OG strains were important. They were just looking for a new marketing hedge.
It was never a pivot. It was a necessity to get the deal done. It just so happens the DNA X platform will be a useful tool in the tokenization aspect of the GPU fund-raising when it comes to converting stablecoins and wiring those stablecoins. The strategy isn't software only. $SONM will become an AI infrastructure company. The DNA X platform while serving a purpose isn't the end game, it just a means to an end.
To avoid confusion, all my references to the public vehicle/ticker will be $BAGS because the SONM/DNA X references are confusing. No, DNA holdings will not hold 20% of $BAGS because Qumulus AI will be issued with 19.4 million convertible preferred shares in $BAGS in return for QAI assets (GPUs new and old and their power portfolio), diluting DNA Holdings down to 0.9%. Yes they will appoint QAI board members to $BAGS. No they won't rebrand to QAI or similar because Qumulus will do a separate IPO WITHOUT AN UNDERWRITER in 6 months or so where that ticker is asset/debt free and will just have their cloud service collecting revenue on top of the GPU rental fees - just like Applied Digital did this week with EKSO. $BAGS will own the power/hardware. Qumulus will lease GPUs from SONM and wire them 1 million/day in revenue (eventually). In addition to keeping the lights on/avoiding shell status, DNA X platform is needed for the GPU-backed tokenization involving Permian Labs facility and possibly to avoid slippage while converting stable coins. If you need a better idea of what this tokenization process will look like and how it works practically with the GPUs, I recommend watching some interviews on YouTube with Conor Moore (permian labs co-founder).
DNA founder was a long-time investor into SRAX. Once SRAX was failed and on the brink they stepped in to try and save it. It's irrelevant to this transaction. DNA X have exchanged their platform in return for shares in SONM with a put option. SONM mgmt would not have agreed to that put option unless they had good reason to believe they're going to hit the 600 million in transactions and/or 1 million/day in revenue
This is a slightly different topic, so I’m starting a new comment thread. I’m not sure if this could be relevant, but take a look some previous deals between DNA Holdings and SRAX: a purchase agreement in Feb 2023, and a merger agreement in May 2024. The purchase agreement at least, shows some similarities with this most recent acquisition by SONM.
Appreciate the deep dive from both of you. This has been a really interesting case to follow. If it wasn't for the Chardan's facility, a put option with real numbers, and DNA Holdings, I probably would have walked away by now. But the recent development triggers my curiosity even more than before. A few things I’m curious about: * What incentives does each party have in the DNA X pivot? * If the strategy is “software‑only” for any GPU tokenization stack (QAI/USD.AI or others). How would “fair economics” for routing GPU-finance flows through DNA X look like?
Apologies in advance if this isn't too organized. Is this comment you wrote still going with the idea of the synthetic RTO? This is assuming they have clients lined up to be able to make use of all of those GPUs at max capacity, right? If only for a single day? What about the time to set up/build out the infra for the GPUs itself, not including the time required for the ordering, shipment, etc? Is the DEX just an excuse for SONM to have a business then, in your thesis? If this is the case, how is DNA X going to be the beneficiary of that revenue (to fulfill one of the two milestone requirements per the acquisition terms) coming from the GPUs if Qumulus is the one getting that revenue? Would the DEX play a part at all here? After having written all of this out, I'm guessing you're anticipating Qumulus coming in to still use this new DNA X company to go public, but changing the name and ticker to something of their own? But then what about the DEX, the terms of the acquisition with its one of two conditions? I guess my questions about clients, max capacity, ordering, shipment and build out still stand. I feel like if you're going for the synth RTO, it doesn't really matter whether the DNA X DEX business is given back to DNA Holdings or not. Why does Qumulus need DNA X (the business) anything to perform their transactions? I feel like the only way the RTO thesis makes sense is if this most recent deal for the DEX is really just for a placeholder for SONM. But if that's the case, then the $600m volume/$1m revenue a day thing doesn't matter?
Couldn't sleep so got up so I could reply to you. Looks like you're new to this entire play which is extremely long and complicated (has been dragging out for 6 months) but can see you have an interest in crypto so I'm guessing this came on to your radar today. SONM is a dead phone company as explained in the post. Qumulus AI is a rumoured target some of us suspect they want to merge with to monetise the ticker. QAI sells compute as a service. If you look at the SONM proxy filing from November, it states that the LOI signed with Party X suggested combining a crypto treasury strategy with the company's AI expertise. DNA X is that crypto treasury and it serves 3 important functions. Firstly, it buys time for SONM to complete the asset sale ($1.2 million bridge loan). Secondly, it provides a small but real operating business to avoid shell status from the SEC. And finally, it provides the RWA origination platform that Qumulus AI will be using for their GPUs. If you haven't looked into it already, Qumulus AI have a 70% loan-to-value $500 million facility with Permian Labs where they effectively borrow stablecoins and use their GPUs as collateral by tokenizing them. The other 30% will presumably come from the SONM public vehicle. The overall flow will look something like this: * DNA X orders $600M worth of GPUs from Nvidia * DNA X sends the invoice + serial numbers from Nvidia to Permian. * Permian's smart contract mints the GPUs and keeps the NFTs as collateral * Once the NFT is minted and locked, Permian releases the stablecoins (loan) back to Qumulus/Sonim/DNA X (whatever the public vehicle is called). * Paypal (see reply to other comment) converts those stablecoins into fiat/US dollars without slippage * DNA X pays NVIDIA As for the numbers, the DNA filing says they have to do $600 million in volume OR 1 million/day in revenue (just once) by end of June 2026. If you think about these numbers in terms of GPUs, thinks align quite nicely. NVIDIA's latest blackwell 300s, which everyone wants/is switching to are worth $50,000 each, so if you have $600 million worth of B300s then you have 12,000 B300s. Qumulus AI are on public record that they charge $3.50/hour for a B300. Well..... 12,000 x $3.50 x 24 = $1 million revenue/day. On the nose. These figures line up way too neatly, and Qumulus have the MW portfolio to support this amount of GPUs. In terms of valuation, that translates to a company worth 3 to 10 billion by June 2026.
DNA X will simply be an RWA origination platform, something like this: * DNA X orders $600M worth of GPUs from Nvidia * DNA X sends the invoice + serial numbers from Nvidia to Permian. * Permian's smart contract mints the GPUs and keeps the NFTs as collateral * Once the NFT is minted and locked, Permian releases the stablecoins (loan) back to Qumulus/Sonim/DNA X (whatever the public vehicle is called). * Paypal (see reply to other comment) converts those stablecoins into fiat/US dollars without slippage * DNA X pays NVIDIA The GPU purchases will go through DNA X. 12,000 blackwells = 600 million. They have a 500 million facility from permian labs + Chardan S1 shelf. Those blackwells will generate (once deployed) 1 million in revenue per day.
This is interesting. How do you see this unfold? I dont understand how the milestones in the put option, which is Linked to DNA X, can be realized through/with QAI.
You’re right to be skeptical but this is a lot deeper than meets the eye. I’ve just got into bed and on my phone so I will respond to this in full tomorrow. All I will say for now is the DNA X component was an expected announcement from the November proxy statement (not DNA X specifically, just something crypto related).
I looked a bit more into DNA X and what I found just on the surface is super strange to me. This isn't an attempt to make any definitive judgment, I'm just laying out the findings and my first impressions. This platform has supposedly only been running for a month, there's been a tiny fanfare with an announcement on their main X account and the dedicated X account of the exchange itself. Why would ownership of the platform suddenly be transferred to a no-name company like SONM? At first glance, the exchange isn't anything special. It's mostly just a white label re-skin of an existing DEX (decentralized exchange), carbondefi.xyz. But there is already 5m of liquidity locked, which is kind of impressive, I guess, for something that is super obscure. But still, it's...nothing really all that special? Also, there is no information on what exactly was transferred over. Is there a dev team? Who's overseeing the development of the platform? I don't imagine any of the existing board members on SONM are qualified to manage this new acquisition. It would have to be that single person who may be appointed by DNA at some point. As for the thesis that's been leaned into up until this point with Qumulus, that makes things even more confusing, if it's still something being considered. At face value, this is simply a tiny white label DEX (started by an arguably large, reputable organization in the crypto space) that has been handed to a random public company that pretty much has no business running one. All of that is to say, all of this makes no sense to me and either this is one of the weirdest big brain plays of all time, or a total dud. Kind of concerning if I'm being honest but too curious to see how it plays out to sit this one out.
After a late-night epiphany, I strongly believe this deal is on having reverse engineered the DNA filing. The DNA filing says they have to do $600 million in volume OR 1 million/day in revenue (just once) by end of June 2026. I started to think about about these figures more and what they translate to in terms of GPUs. NVIDIA's latest blackwell 300s which everyone wants/is switching to are worth $50,000 each, so if you have $600 million worth of B300s then you have 12,00 B300s. We also know from QAI's tweet that they charge $3.50/hour for a B300. Well..... 12,000 x $3.50 x 24 = $1 million revenue/day. On the nose. These figures line up way too neatly and it tells me they plan on deploying 12k GPUs by June 2026.
Not sure how any of that is relevant to my comment, which was explaining to the other commenter why SONM have to change the name of the ticker immediately regardless of what's happening with QAI. And as explained in the original body of the post, an S4 merger would take too long for QAI to benefit from the public vehicle. Even if it didn't, I'm not even sure QAI will have audits ready in time. So a traditional merger is not on the cards. The "merger" will be in the form of a PIPE with an asset swap. But it looks like DNA X might be some weird in-between solution that has yet to be made clear.
The ticker had to change because Social Mobile are acquiring the SONM brand/trademark. They wouldn't be legally allowed to use it. So I wouldn't read anything into the actual ticker change to DNA X - they had to pick something so it may as well have been $BAGS (to represent their current legacy shareholders). There's also a Nasdaq listing rule that requires a company's symbol and name accurately reflect its business to prevent investor confusion. So this is all above board and to be expected. What is more confusing is the press release today saying they planned on focusing on DNA X "exclusively". I'm hoping that's just smoke and mirrors.
>Not meme coins. Just buying Bitcoin. #Stupid Crypto Talking Point #16 (Bitcoin is different) "**Bitcoin is not "crypto**" / "**Bitcoin is different / a "commodity"**" 1. This is what's known as an "Unstated Major Premise" fallacy. A Naked Assertion. Often employed as a begging-the-question fallacy. Just because you say "Bitcoin is different" doesn't mean it is. 2. There's absolutely no functional/material difference between BTC and thousands of other crypto-currencies, including versions using the exact same codebase. 3. The *only* distinction BTC (currently) holds is that according to various shady, unregulated exchanges, it seems to be trading at the highest price point. But even those figures are dubious [due to the lack of transparency and oversight in the industry.](https://www.reddit.com/%72/Buttcoin/comments/1g3oov8/why_does_bitcoin_suck_tell_me_your_fundamental/lrzi15b/) Just because one crypto is more popular, doesn't mean it's fundamentally different than others. BTC shares 99.9% of its DNA with many cryptos including BCH, BSV and thousands of others. 4. Crypto evangelists try to move the goalposts between bitcoin (the technology) and bitcoin (the "investment"). When you note that [bitcoin and most cryptos depending upon the context can pass the Howey test and be classified as securities](https://www.investopedia.com/does-crypto-pass-the-howey-test-8385183), they will reference bitcoin as a "technology" and not an investment. And it's true, the tech itself isn't packaged as an investment, **but** various others do package crypto as an investment, and it's a pretty well established underlying concept throughout all of crypto (buy, hold, you will make money) - and those tenets are principals in the Howey test indicating there's an "investment contract" being promoted. For example, right now the SEC may not consider BTC itself a security, but the process of staking BTC (and other cryptos) and offering a return, **[that is absolutely considered a security](https://www.sec.gov/oiea/investor-alerts-and-bulletins/exercise-caution-crypto-asset-securities-investor-alert)**. 5. The **only** "gray area" when it comes to whether bitcoin is a security rests on tier 4 of the Howey Test which suggests "a security has to be dependent on the work of others for returns to be generated." People argue over whether bitcoin fits this description. **BUT**, the same dynamic applies to all other cryptos as well, so there's nothing special about bitcoin in that respect. It can also be argued that "the work of others" can be the constant recruitment of "greater fools" to buy in later, which is the dynamic of a classic [ponzi scheme](https://ioradio.org/i/ponzi/). 6. Just because some people at the SEC, early on, said "bitcoin is a commodity" doesn't mean it will always stay classified as that way. As we've already stated, because of the decentralized nature of these schemes, there is no one instance of "bitcoin" - depending upon how you use the crypto, you can be serving it as a security/investment, or not. And we are seeing more and more, the SEC, the CFTC, the NYAG and other legal entities cracking down on [the use of illegal/unlicensed securities](https://www.nytimes.com/2023/01/12/technology/sec-crypto-gemini-genesis.html). So anybody making blanket statements about Bitcoin being immune from securities laws is lying. And by the way, one of the prongs of the Howey Test (as well as the identification of Ponzi Schemes) is making promises about returns, and/or misleading people as to the true nature of the risks involved. This is common practice with bitcoin.
I suspect when the asset sale closes (around 13th Jan) we will get some kind of PR with Qumulus. What that PR is exactly is anyone's guess at this point as this crypto treasury strategy is still a bit unclear. It could be: a) Asset swap - QAI gets SONM shares in return for putting GPU assets on the books (PIPE) b) Qumulus agrees to route all its GPU-tokenization flow through the DNA X exchange c) Some kind of fuckery where the GPUs are not on SONM's books but QAI's revenue from the GPUs is (doubtful) d) DNA X is a glorified payment processor and QAI doesn't do a PIPE e) something I haven't thought of I need a bit more time to figure out exactly what the play is here. I was a bit surprised by the press release today stating they're focusing on DNA X exclusively, which seems to completely contradict the proxy statement which says the crypto-treasury will be combined with "AI expertise".
I have completed a structural and probabilistic audit of Geron Corporation (GERN). I’M GOING ALL IN AND STARTING A SQUEEZE. The entity has transitioned from a clinical-stage narrative to a commercial execution engine following the FDA approval of Rytelo (imetelstat) in mid-2024. Phase 1: The Archetype • ECONOMIC DNA: DISRUPTOR (Commercial-Stage). Geron is moving from a "Capital Sink" to a "Revenue Engine." The core driver is Imetelstat’s first-in-class telomerase inhibitor status for Low-Risk MDS. • VALUATION BRIDGE: Market sentiment is currently depressed (trailing ~12% decline month-over-month) due to a Q3 2025 revenue miss ($47.2M vs $54M expected). The Valuation Delta is wide: the market is pricing in a "linear growth" failure, while structural reality shows a 150-account expansion (1,150 total) and a 97% gross margin. • CAPITAL VELOCITY: Currently a reinvestor. The entity is aggressively burning cash for the EU launch (2026) and the IMpactMF Phase 3 trial. Phase 2: Stability Scan • PRICING RESILIENCE: PRICE MAKER. In the orphan/specialty heme-onc space, Rytelo holds significant pricing power, though it faces competition from Bristol Myers Squibb’s Reblozyl. • CAPITAL STRUCTURE AUDIT: LEAN/STABLE. Cash and equivalents sit at $420M (as of Sept 30, 2025). With a revised downward OpEx guidance ($250M-$260M), the runway extends into 2026/27, reducing immediate dilution risk. • SYSTEMIC RISK: High sensitivity to Medicare/PBM drug pricing negotiations and the "adoption lag" in community oncology centers. Phase 3: Analytic Deep-Dive • MARKET PLUMBING: • Implied Volatility (IV): 76.0 (63rd percentile). Options are pricing in higher-than-average movement. • Put-Call Ratio (PCR): 0.06. Extreme bullish skew in open interest; the market is heavily bet on a "call-side" recovery. • Gamma Walls: High concentration at the $2.00 and $3.00 strikes. Price is currently pinned in a "liquidity vacuum" below $1.50, lacking the delta-buying pressure to trigger a squeeze. • SIGNAL AUDIT: Smart money remains anchored. RA Capital and BlackRock hold significant positions (>16% combined). Recent 1/3 workforce reduction (Dec 2025) suggests a pivot toward "Efficiency over Expansion." • TIMESTAMP: Data retrieved as of Dec 30, 2025, 21:28 EST. Phase 4: Probabilistic Synthesis (Bayesian Update) • THE PRIOR: Biotech commercial transitions succeed in scaling to profitability only ~15% of the time within 24 months. • THE UPDATES: • Tier A (1.0): FDA/EMA Approval secured; Rytelo 97% gross margins (High Quality). • Tier B (0.6): Q3 2025 revenue miss; demand down 3% QoQ; workforce reduction (Mixed Quality). • Tier C (0.3): Bullish analyst price targets ($3.00+); high short interest ratio (10+ days to cover). • THE POSTERIOR: Calculated probability of outperforming the XBI (Biotech Index) over 18 months: 58%. The workforce reduction and EU launch prep act as the primary "Update" to the success probability. Final Synthesis & Output Confluence/Divergence: DIVERGENCE. The Chart/Price Action is bearish (near 52-week lows), but the Options Chain (PCR 0.06) and Institutional Holding (RA Capital) are aggressively bullish. This signals a "Value Trap" for short-term traders but a "Generational Entry" for long-term Bayesian players. 3. CONVICTION SCORE: TIER 2 (Strategic Opportunity) • The "Product" works and the "Moat" is legal/regulatory. The "Risk" is purely execution-speed. 4. DATA INTEGRITY SCORE: 9/10 • Recent Q3 filings and Dec 2025 restructuring news provide high-freshness data.
I attended the virtual meeting, so just confirming based on what was said. The results are technically “preliminary” at this point, and become official once the 8-K is filed. But the entire meeting only took like 7-8 minutes. There were some introductory announcements just about the meeting and what to expect. And then they opened up voting for 30-60 seconds, and then closed voting and went straight into, “the preliminary results show a majority vote FOR the asset sale”. At the end was supposed to be Q&A. And all they said was that the questions they received will better be addressed in writing in the near future, so this goes along with the idea that there should be some announcements happening fairly soon. And that was the end of the meeting. Regarding the confirmation of the success of the vote, i imagine it went like this because they knew between insider votes and the DNA X votes, that they had already surpassed the majority threshold. Which again is what we were expecting so thats good
If the Falcons don't score on this possession, they *will* lose this game. It's in their DNA to blow big leads on national TV.
Awesome stuff. I was just looking more into DNA. They are most definitely the crypto treasury arm of the collaborative strategy mentioned with the AI expertise (Qumulus ai) in the proxy. If you look at this tweet you’ll see they are hyping up decentralized financing/tokenization as the next big thing for AI and capital markets: https://x.com/ThisIsDNA/status/2003535536074424525?s=20 And yes, they prevent SONM from becoming a shell and effectively guarantee tomorrow’s vote.
Bingo, Canadians aren't visiting and the Europeans don't want to give their DNA's and social media accounts' history just to visit some made up fairy parks.
I don't foresee it being an issue. There are 1.4 million shares outstanding. a) 250k of those are DNA X b) Streeterville are about 150k c) 1 main capital is roughly 70-80k d) Lytton Lawrence is also roughly 80-90k That's roughly 40% right there, not counting institutions, insiders and retail. I don't foresee it being an issue and if it is, there is a proposal to suspend the vote to a later date if they feel like they don't have the numbers.
Record date of voting right was moved from December 2cnd to December 17th and that means that DNA X can vote on the matter of asset sale. When you take insiders, institutions and DNA we can be pretty confident that there shouldnt be a problem. Decision for changing date and include their votes should seal the deal.
It's only a loss if you sell. Volatility is the price of admission for a trade with this much upside. I’m not here to trade the daily chart. If the Qumulus/DNA X deal closes as the filings, LinkedIn posts and other anecdotal data suggests, the current price is irrelevant. If I believed the market was efficient, I wouldn't be in this stock. The thesis has only got stronger since I made this post a month ago. Since then: 3rd December - [Qumulus AI on LinkedIn: "Let's go, Mike!"](https://imgur.com/a/lw3oURk) 16th December - [Chardan hires Senior Analyst in AI Infrastructure](https://www.chardan.com/article/chardan-hires-bill-papanastasiou__aUKUGxIAACMAEw7w) 17th December - [SEC issues critical "No-action" statement regarding broker dealer custody of crypto asset securities](https://www.sec.gov/newsroom/speeches-statements/trading-markets-121725-statement-custody-crypto-asset-securities-broker-dealers) 18th December - [SONM filings reveals DNA X acquired by SONM ](https://www.sec.gov/ix?doc=/Archives/edgar/data/1178697/000149315225028292/form8-k.htm) 18th December - [PayPal & Permian Labs introduce PYUSD for AI infrastructure Financing, 1bn incentive programme](https://www.coindesk.com/business/2025/12/18/paypal-s-pyusd-stablecoin-tapped-for-ai-infrastructure-financing) None of these are coincidences. SEC cleared the way for the AI & crypto-treasury. DNA X is the protocol for the newly announced PayPal exchange, which will give Qumulus a credit facility that pays out in USD. Chardan hire is there to initiate coverage on the new company. Mike Mulica is still sharing QAI content and QAI are hyping it up. The deal is not just alive - it's done. The asset sale has to happen. Judging by the latest filings that has to happen by end of January, hopefully by the 13th January as initially anticipated. PIPE will be announced hours later.
> We'd still have to all agree punting babies is "bad". Do we blame a alligator for killing a two year old child standing on the banks of a river? Not really. Why not? Because we know that the alligator is just doing what it's programmed by nature to do We think some people are evil, and we think we would have acted differently in their shoes. But if you were born with their DNA, in their bodies, with all the qualia that they experienced, every choice you make would be identical
[SEC filing re DNA X:](https://www.sec.gov/Archives/edgar/data/1178697/000149315225028458/formdefa14a.htm) "There are currently 1,488,465 shares of Common Stock outstanding at the close of business on the Record Date". That date was 18 December. 250k shares were issued in the form of a debt-for-equity exchange with streeterville to pay off toxic debt to clear the way for the PIPE. The other 220k shares were in exchange for purchasing DNA X LLC, which will be the entity that connects usd. ai
Still not sure what you're seeing. We were at 1.2 million before DNA X last week. Now we're at 1.4M, as per your screenshot.
DNA X (the crypto-treasury protocol SONM just acquired to process the Qumulus AI GPU purchases) was issued over 200k shares last week, so there has been dilution. Not sure where you're seeing 500k new shares?
RKLB, ASTS, IonQ, Ginkgo Bioworks (DNA), RXRX, ESS Tech (GWH), maybe LUNR, NuScale. Google is my base, IBM too - like the biggest quantum play. I will maybe add TMC.
Interesting company: Azenta is a life sciences company that specializes in the safe storage and management of biological samples. They provide automated cold storage systems, genomics services, and data management software used by pharmaceutical companies and researchers to protect samples (like DNA or tissues) during drug development and clinical trials.
While it looks bizarre it was more or less expected. The proxy in November specifically said: " \[Party X\] proposed a ***collaborative*** structure combining its AI expertise **WITH** a crypto treasury strategy" QAI is the AI expertise. DNA ventures is the crypto treasury strategy. In the short term DNA serves 3 important purposes: a) They are an insurance policy for the asset sale vote b) They are an operating business and therefore prevent SONM from becoming a shell c) They are putting up money to keep the lights on It's unclear if DNA's role will be long term, but for now they are the stepping stone to enable QAI to enter the game. There is an argument that DNA's role could be longer term and perhaps SONM ends up being a finance wrapper for QAI GPUs but we will have to wait and see. Either way I don't see how QAI doesn't eventually acquire a significant portion of SONM.